Based on the results from clinical CRC tissues and public TCGA databases, our study revealed increased CLDN2 expression in CRC tumours compared with paired adjacent normal mucosa and predicted shorter overall survival in CLDN2‐high patients. The gene discussed is CLDN2; the disease is colorectal carcinoma.